Fudan-Zhangjiang
6885057.281.96% ( +0.14 )
Fudan-Zhangjiang (688505)
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd., engages in the research, development, manufacture, and sale of biopharmaceutical products in the People's...
- Open
- 7.22
- High
- 7.33
- Low
- 7.16
- Prev. Close
- 7.14
- Volume
- 51.06K
- Turnover
- 37.11M
- Avg Price
- 7.27
- Bid/Ask Ratio
- --
- Amplitude
- 2.38%
- 52wk High
- 11.38
- Volume Ratio
- 0.47
- Turnover Ratio
- 0.72%
News
- Tip Ranks · Jul 2 at 04:40 AM
Fudan Zhangjiang Boosts Yield on Idle Cash With RMB210 Million SPD Bank Deposit
- Tip Ranks · Jul 2 at 04:40 AM
Fudan Zhangjiang Invests RMB150 Million in Low-Risk Bank of China Structured Deposit
- Tip Ranks · May 28 at 06:57 AM
Fudan-Zhangjiang Bio-Pharma Adopts Performance-Linked Pay Rules for Top Executives
- 同壁财经 · May 21 at 10:21 PM
2026 ASCO | Fudan-Zhangjiang anti-Trop2 antibody conjugate BB05 drug used for the treatment of non-small cell lung cancer Phase I clinical study results published
- Tip Ranks · Apr 7 at 06:18 AM
Fudan Zhangjiang Invests RMB210 Million in Low-Risk SPD Bank Structured Deposit
- AASTOCKS · Mar 29 at 07:13 AM
"Performance" Shanghai Fudan's annual net profit is 232 million RMB, a decrease of 59.4%, with a dividend of 0.58 RMB per 10 shares
